Identification
Personal identification
- Full name
- Vera Neves
Citation names
- Neves, Vera
Author identifiers
- Ciência ID
- 671C-1860-A160
- ORCID iD
- 0000-0002-2989-7208
- Google Scholar ID
- https://scholar.google.pt/citations?hl=en&user=R_cciXIAAAAJ&view_op=list_works&gmla=AJsN-F5wwYFaAZznL84T8FcHytBg9jtPnpwK6vXYprEf5knQDJpi1SQWBl7NNm64DvF4i3ZvBTM1QXl9wsSBqtyPqMRV5pexvlJlrCSNQteWQqYJ-Q_gn68
Telephones
- Telephone
-
- 217985136 Ext.: 47256 (Professional)
Addresses
- Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Professor Egas Moniz, Edifício Egas Moniz, 1649-028, Lisboa, Lisboa, Portugal (Professional)
Websites
- https://www.linkedin.com/in/vera-neves-83950113/ (Social media)
Knowledge fields
- Natural sciences - Biological Sciences - Biochemistry
- Medical and Health Sciences - Medical Biotechnology - Biomaterials
- Medical and Health Sciences - Basic Medicine - Neurosciences
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Advanced (C1) |
Education
Degree | Classification | |
---|---|---|
2017/06 - 2017/06
Concluded
|
iMM MasterClass in Fundamentals of Innovation and Tech Transfer (Outros)
Instituto de Medicina Molecular, Portugal
|
|
2016/06 - 2016/06
Concluded
|
Leadership and Management skills course for scientists. (Outros)
hfp consulting, Germany
|
|
2013/05 - 2013/06
Concluded
|
Laboratory animal science accreditation (Outros)
Instituto de Medicina Molecular, Portugal
|
|
2007/04/01 - 2011/02/06
Concluded
|
Bionanotechnology (Doutoramento)
Major in nanomedicine
University of Surrey, United Kingdom
"Carbon nanotubes: Feasibility as nano-bio agents to target cancer" (THESIS/DISSERTATION)
|
|
1999/09/15 - 2004/12/09
Concluded
|
Biotechnology engineering (Licenciatura)
Universidade Lusófona de Humanidades e Tecnologias, Portugal
"Physiological aspects of yeast Debaryomyces hansenii" (THESIS/DISSERTATION)
|
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2022/10/01 - Current | Auxiliary Researcher (Research) | Instituto de Medicina Molecular, Portugal |
2018/08/01 - 2022/09/30 | Contracted Researcher (Research) | Instituto de Medicina Molecular, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2014/09/01 - 2018/07/31 | Postdoc (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2018/02/07 - 2018/07/06 | Visiting Researcher (Research) | ProteoDesign, Spain |
2012/04/01 - 2014/02/28 | Postdoc (Research) | Instituto de Medicina Molecular, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2007/04/01 - 2011/02 | Research Trainee (Research) | University of Surrey, United Kingdom |
2008/11/01 - 2009/02/01 | Visiting Researcher (Research) | Zachodniopomorski Uniwersytet Technologiczny Instytut Fizyki, Poland |
2005/03/01 - 2006/10/31 | Researcher (Research) | Biopeptides corp, United States |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2019/04/01 - Current | Invited Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Medicina, Portugal |
Universidade de Lisboa Faculdade de Medicina, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2024/01/08 - Current | Development of an organ-on-a-chip of triple-negative breast cancer metastases for drug screening (TNBC-BM model),
Centro de Tecnologia e Inovação (CTI) - iMM
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Instituto de Medicina Molecular
Ongoing
|
2024/01/02 - Current | AVITHRAPID: Antiviral therapeutics for rapid response agaisnt pandemic infectious diseases.
101137192
Researcher
Instituto de Medicina Molecular, Portugal
|
European Commission
Ongoing
|
2022/02/02 - Current | Search-AnD-See - Towards the development of a nanoparticle for early diagnosis of Alzheimer¿s Disease, based on the reversible
translocation of the blood brain barrier.
PTDC/BTM-MAT/2472/2021
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2022/01/01 - Current | MolNanoBone - A molecular and nano approach to target the RANK-TRAF6 interface for bone metastases treatment
PTDC/QUIOUT/3854/2021
Researcher
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021/12/15 - Current | Breast-Brain-N-BBB - Protecting the brain from metastatic breast cancer
HR21-00605
Researcher
Instituto de Medicina Molecular, Portugal
|
Obra Social La Caixa |
2021 - Current | TRESPASS2TREAT - A novel approach in pharmacotherapies for breast cancer patients with brain metastasis.
PTDC/BIA-BQM/5027/2020
Researcher
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019/09/01 - Current | ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected
individuals
Researcher
Instituto de Medicina Molecular, Portugal
|
European Commission
Ongoing
|
2020/11/01 - 2023/10/31 | Epiepinet: Epileptogenesis and epilepsy network: from genes, synapses and circuits to pave the way for novel drugs and strategies
952455
952455
Researcher
Instituto de Medicina Molecular, Portugal
|
EU Framework Programme for Research and Innovation Euratom
Ongoing
|
2019/04/01 - 2022/12/31 | Development of a blood-brain barrier shuttle platform for applicability in Alzheimer's disease
FCT/NKFIH, 2019/2020
Researcher
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021/10/01 - 2021/12/31 | Selecting anti-Zika virus drug leads able to translocate the blood-placental and blood-brain barriers. Combining innovative
and effective translocating peptides with new antivirals to target Zika across barriers.
PTDC/BIA-VIR/29495/2017
Principal investigator
Instituto de Medicina Molecular, Portugal
Universitat Pompeu Fabra - Campus de la Comunicació Poblenou, Spain Universidade Federal do Rio de Janeiro, Brazil |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018/06/14 - 2021/06/13 | Development of a novel class of antibody-drug conjugates molecules for cancer treatment
PTDC/BTM-SAL/32085/2017
PI of participating institution (iMM)
Universidade de Lisboa Centro de Investigação Interdisciplinar em Sanidade Animal, Portugal
Instituto de Medicina Molecular, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal Centro de Ciências e Tecnologias Nucleares, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2018 - 2021 | Fighting Zika virus with antiviral peptides and conjugates translocating blood-placental and blood-brain barriers
HR17-00409
Researcher
|
Obra Social La Caixa
Ongoing
|
2016/05 - 2020/02/29 | TRANSDRUG - Peptides for Blood-brain barrier transmigration and drug delivery
PTDC/BBBNAN/ 1578/2014
Principal investigator
|
Fundação para a Ciência e a Tecnologia |
2016/05 - 2019/10/31 | Alzheimer3D: Trifunctional Conjugates for the Selective Drug Delivery in Alzheimer’s Disease
PTDC/QEQMED/ 5512/2014
PI of participating institution (iMM)
|
Fundação para a Ciência e a Tecnologia |
2016/05/01 - 2019/08/31 | Overcoming the Brain Drug Delivery Bottleneck: Development of single domain antibodies for brain targeting and drug delivery
across the Blood-Brain Barrier.
PTDC/BBB-BIO/0508/2014
PI of participating institution (iMM)
Universidade de Lisboa Centro de Investigação Interdisciplinar em Sanidade Animal, Portugal
Instituto de Medicina Molecular, Portugal Centro de Ciências e Tecnologias Nucleares, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2017/02/01 - 2019/01/31 | INPACT- Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development,
product market targeting, training, and communication
644167
Researcher
Instituto de Medicina Molecular, Portugal
|
Concluded
|
2016/01/01 - 2017/01/31 | Development of a new immunoliposome drug delivery system for treatment of pneumococcal meningitis
UID/CVT/00276/2013
Researcher
Universidade de Lisboa Centro de Investigação Interdisciplinar em Sanidade Animal, Portugal
|
Concluded
|
2007/04/01 - 2011/02/06 | Multifunctional carbon nanotubes for biomedical applications
MRTN-CT-2006-035616
MRTN-CT-2006-035616
PhD Student Fellow
University of Surrey, United Kingdom
|
N/A
Concluded
|
Contract
Designation | Funders | |
---|---|---|
2023/02/01 - Current | Innovative diagnostic tool to overcome the blood-brain barrier to blood-detection of early stages of Alzheimer disease
2022.11370.BD
Supervisor
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2022/10/01 - Current | Diagnostic tool for Alzheimer’s disease based on a proprietary blood-brain barrier peptide shuttle-nanoparticle
2021.00895.CEECIND
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019/10/01 - Current | Multifunctional magnetic nanoparticles for targeted Alzheimer Disease theranostics
SFRH/BD/148588/2019
Supervisor
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021/03/01 - 2025/02/28 | Anticancer activity of a minibody against triple negative breast cancer brain metastases
UI/BD/151171/2021
Supervisor
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2016/05/01 - 2022/04 | Kyotorphin as new pharmacological therapeutic strategy for Alzheimer’s Disease
PD/BD/114337/2016
Supervisor
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2017/01/01 - 2022/03/23 | Trans-BBB peptides for targeting brain metastases
PD/BD/128281/2017
Supervisor
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2014/09/01 - 2018/07/31 | Peptides for blood-brain barrier transmigration and drug delivery – novel therapies for the central nervous system (CNS).
SFRH/BPD/94466/2013
PTDC/BBB-NAN/1578/2014
Post-doc Fellow
Instituto de Medicina Molecular, Portugal
Centro de Ciências e Tecnologias Nucleares, Portugal Universidade de Lisboa Centro de Investigação Interdisciplinar em Sanidade Animal, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2012/04/01 - 2014/02/28 | DoIT – desenvolvimento e operacionalização da investigação de translação (QREN). Secção D – PPS – sdAb+péptido- Investigação
translacional em Alzeimer.
QREN
Post-doc Fellow
Instituto de Medicina Molecular, Portugal
|
Concluded
|
Outputs
Publications
Book chapter |
|
Conference poster |
|
Journal article |
|
Intellectual property
Patent |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2023/11/28 | Peptide Shuttles to improve therapeutic action in the central nervous system | XVIII Iberian Peptide Meeting
Peptide society (Sesimbra, Portugal)
|
2023/01/26 | Peptide shuttles for receptor independent transport across the BBB | Symposium "Cell Based Research in Toxicology and Drug Design”
Institute for Medical Reserach and Occupational Health, Zagreb, Croatia (Zagreb, Croatia)
|
2022/06/10 | Crossing Biological Barriers using Peptides. | Institute visit
Wyss Institute (Boston, United States)
|
2021/10/16 | Development of a Blood Brain Barrier Peptide Shuttle and its conjugation to an Fc domain for brain delivery of therapeutic biomolecules | XXI National Congress of Biochemistry
(Évora)
|
2021/03/19 | Peptide shuttles for receptor-independent transport across the BBB | Models of the Blood-Brain Barrier Scientific Tools to Target the Brain
Faculdade de Farmácia da Universidade de Lisboa (Lisbon, Portugal)
|
2018/02/06 | Novel Peptide delivery systems for Blood brain barrier translocation with a focus on Alzheimer’s disease | 16th Iberian peptide meeting
(Barcelona, Spain)
|
2017/11 | Novel peptides derived from Dengue virus capsid protein translocate reversibly the blood-brain barrier through a receptor-free mechanism | iMM annual PDA meeting
(Lisboa, Portugal)
|
2017/10 | New cell-penetrating peptide for drug delivery to the brain. | 5th Italian Experience in Biomedical Research: Young Minds at Work
(Lombardy, Italy)
|
2016/02/11 | A novel peptide platform derived from Dengue virus for drug delivery into the brain | EPI XV – Iberian peptide meeting
(Porto, Portugal)
|
2009/06/24 | Carbon nanotubes: Interaction with cells for gene targeting | NT09: Tenth International Conference on the Science and Application of Nanotubes
(Beijing , China)
|
2009/06/15 | Carbon nanotubes: Interaction with cells for gene targeting | 2nd ESF Summer School Nanomedicine
(Lisbon, Portugal)
|
2008/04/10 | Carbon nanotubes: Delivery to cancer cells for gene targeting and therapy | INNANO conference
(Innsbruck, Austria)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2023/10/01 - Current | Identification and characterization of cancer stem cells in breast cancer biopsies and comparison with cancer cell lines
Supervisor
|
Medicine (Degree)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2023/02/01 - Current | Innovative diagnostic tool to overcome the blood-brain barrier to blood-detection of early stages of Alzheimer disease
Supervisor of Patricia Fraga
|
Instituto de Medicina Molecular, Portugal
|
2023/01/05 - Current | 26.º Programa “Educação pela Ciência” / Bolsas CHLN/FMUL, project Development of a 3D Blood-Brain Barrier (BBB) Microfluidic
model to assess transport of peptide-funcionalized Nanoparticles"
Supervisor of João Grancho
|
Medicine (Degree)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2022/09/15 - Current | Impact of psychostimulants and alcohol on the blood-brain barrier properties
Supervisor of Rodrigo Alarcão
|
Mestrado em Neurociências (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2021/03/01 - Current | Anticancer activity of a minibody against triple negative breast cancer brain metastases
Supervisor of Catarina Gonçalves
|
Biochemistry (PhD)
Instituto de Medicina Molecular, Portugal
|
2019/10/01 - Current | Multifunctional magnetic nanoparticles for targeted Alzheimer Disease theranostics
Co-supervisor of Catarina Isabel Parente Chaparro
|
Nanotecnologias e Nanociências (PhD)
Universidade Nova de Lisboa Centro de Investigação em Materiais, Portugal
Instituto de Medicina Molecular, Portugal |
2023/09/15 - 2024 | Design of peptide-based inhibitors to tackle triple-negative breast cancer
Supervisor of Alexandra Afonso
|
Biomedical research (Master)
Universidade NOVA de Lisboa NOVA Medical School, Portugal
|
2016/05/01 - 2022/04 | Kyotorphin as new pharmacological therapeutic strategy for Alzheimer’s Disease
Co-supervisor of Rita Belo
|
M2B PhD (Neurosciences) (PhD)
Instituto de Medicina Molecular, Portugal
|
2017/01/01 - 2022/03/23 | Trans-BBB peptides for targeting brain metastases
Supervisor of Marco Cavaco
|
LisbonBioMed program (PhD)
Instituto de Medicina Molecular, Portugal
|
2020/10/01 - 2021/11/12 | Development of a brain metastasis co-culture cellular model for drug testing.
Supervisor of Patrícia Fraga
|
Mestrado em Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
Instituto de Medicina Molecular, Portugal |
2018 - 2019 | Blood based biomarkers for Alzheimer’s disease – an in vitro proof of concept
Co-supervisor of Abeda Ahmad
|
Biochemistry for health (Master)
Instituto de Medicina Molecular, Portugal
|
2015/01/01 - 2018/01/23 | Kyotorphin and its derivatives: Unveiling routes and targets
Supervisor of Juliana Perazzo
|
LisbonBioMed program (PhD)
Instituto de Medicina Molecular, Portugal
|
2017 - 2018 | Importância da utilização de péptidos com capacidade de transmigração da barreira hemato-encefálica em metástases no cérebro
Supervisor of Francisco António de Aguilar Baptista
|
Medicina (Degree)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2015/09/15 - 2017/01 | Peptide optimization for specific delivery to the blood-brain barrier
Co-supervisor of Sara Neves Coelho
|
Neurosciences (Master)
Instituto de Medicina Molecular, Portugal
|
2015 - 2016 | Translocation mechanism of blood-brain barrier by peptides derived from Dengue virus - New drug delivery systems
Supervisor of Rute Eleuterio
|
Biochemistry (Master)
Universidade Nova de Lisboa Departamento de Química, Portugal
|
2015 - 2016 | Development of a theranostic system for central nervous system based on superparamagnetic nanoparticles
Co-supervisor of Mariana Amaro
|
Biochemistry (Master)
Universidade Nova de Lisboa Departamento de Química, Portugal
|
2015 - 2015 | Importância da Utilização de Péptidos com Capacidade de Transmigração da Barreira Hemato-Encefálica na Doença de Alzheimer
Supervisor of Inês Moita Ladeiras Coutinho dos Santos
|
Medicine (Degree)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2021/09/27 - 2021/10/01 | Summer School, part of the EpiEpiNet (Epileptogenesis and Epilepsy Network) Twinning Project, entitled "Trends and Challenges
in Epilepsy Research", involving around 20-25 participants, the audience being mostly PhD students and post-docs from different
countries. (2021/09/27 - 2021/10/01)
Symposium (Member of the Organising Committee)
|
Instituto de Medicina Molecular, Portugal |
2018/06 - 2018/12 | Conference on "Innovative approaches in targeted therapies: Brain, Infections and Cancer." as part of project RISE -INPACT
- innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutic development, product
market targeting, training and communication. (2018/12/13 - 2018/12/14)
Conference (Member of the Scientific Committee)
|
Instituto de Medicina Molecular, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2022/09/23 - 2022/09/24 | EPILEPTOGENESIS AND EPILEPSY NETWORK: from genes, synapses, and circuitries to pave the way for novel drugs and strategies.
EPIEPINET is a European Consortium funded by the European Union.
Symposium
|
3rd Annual Meeting EPIEPINET
Instituto de Medicina Molecular, Portugal
|
2022/05/23 - 2022/05/26 | EATRIS-Plus Summer School in Personalised Medicine
Symposium
|
EATRIS-Plus Summer School in Personalised Medicine
Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
|
2019/07/21 - 2019/07/24 | Poster Presentation - Peptide delivery systems to overcome the Blood-Brain Barrier to treat brain diseases: focus on Alzeimers
disease.
Congress
|
Controlled Release Society Annual Meeting & Exposition |
2019/03/26 - 2019/03/26 | Workshop: The Promise and Pitfalls of Real-world evidence in Alzheimer’s Disease, part of 14th¿ International Conference on
Alzheimer's and Parkinson's Diseases and related neurological disorders.
Conference
|
14th¿ International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders |
2018/08/26 - 2018/08/31 | Poster presentartion: Trans-Blood brain barrier peptides to enhance delivery of therapeutic molecules to treat Alzheimer’s
disease. (P153).
Conference
|
35th European Peptide Symposium |
2017/06/17 - 2017/06/22 | Poster presentation: Novel peptides derived from Dengue virus capsid protein translocate reversibly the blood-brain barrier
through a receptor-free
Conference
|
25th American Peptide Symposium |
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2023/11/27 | Therapeutic application of Argonaute-2 to enhance neurovascular repair and inflammatory restitution in stroke
(Thesis) Arguer
|
Marta Pereira (PhD)
Universidade da Beira Interior, Portugal
|
2023/02/17 | Unravelling and modulating the interplay between breast cancer cells and blood-brain barrier endothelial cells: a new hope
to prevent brain metastasis formation
(Thesis) Main arguer
|
Ana Rita da Costa Garcia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/12/12 | Development of lipid-polymer hybrid nanoparticles as a strategy to treat Alzheimer´s Disease
(Thesis) Main arguer
|
Catarina Cachão Roque (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/11/19 | In Silico design of novel peptides for treating cancer through inhibition of the RANK-TRAF6 interaction
(Thesis) Main arguer
|
Sara Batalha Galhofo Celestino Perdigão (Master)
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Portugal
|
2018 | From rabbit to men: Development of single domain antibodies against gp120 receptor of HIV
(Thesis) Main arguer
|
Isabel Beatriz Fernandes Parreira (Other)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2017/12/18 | Application of Hyperthermia for Cancer Treatment: Synthesis and Characterization of Magnetic Nanoparticles and their internalization
on Tumor Cell Lines
(Thesis) Main arguer
|
Catarina Isabel Parente Chaparro (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
Ad Hoc journal article review
Journal title (ISSN) | Publisher | |
---|---|---|
2022 - Current | Bioconjugate chemistry (1043-1802) | ACS publications |
2019 - Current | Molecules | MDPI |
2019 - Current | Pharmaceutics | MDPI |
2019 - Current | Biomolecules | MDPI |
2017 - Current | Nanomedicina: Nanotechnology, Biology, and Medicine (1549-9634) | Elsevier |
Association member
Society Organization name | Role | |
---|---|---|
2022/04/01 - Current | National Cancer Hub Portugal, NCH-PT | Participant |
2019/04/29 - Current | Controlled Release Society | Member |
2018/05/04 - Current | Children’s Brain Tumour Drug Delivery Consortium (CBTDDC) | Participant |
2017/12/11 - Current | European Peptide Society | Member |
Conference scientific committee
Conference name | Conference host | |
---|---|---|
2018/12/13 - 2018/12/14 | Innovative approches in targeted therapies: Brain, Infections and Cancer | Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2019/04/01 - Current | Módulo II.1 do Mestrado Integrado em Medicina - aulas práticas de bioquímica | Medicina (Licenciatura) | Universidade de Lisboa Faculdade de Medicina, Portugal |
2017/09 - Current | Blood Brain barrier: Challenges to develop new therapeutic tools to act in the brain | Neurosciences (Mestrado) | Universidade de Lisboa Faculdade de Medicina, Portugal |
2017/01/31 - 2018/01/30 | Lecturer - Blood Brain barrier: Challenges to develop new therapeutic tools to act in the brain | LisbonBioMed Program (Doutoramento) | Instituto de Medicina Molecular, Portugal Universidade de Lisboa Faculdade de Medicina, Portugal |
Interview (newspaper / magazine)
Activity description | Newspaper / Forum | |
---|---|---|
2022/07/22 | On World Brain Day, we advocate for health care, education, and research into neurological disorders. The theme for 2022 campaign is “our brain, our future”. Opinion article on "What are the challenges and progress in the development of drugs for the brain?" | Activa magazine (Health) |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2018/12/20 - Current | Role of non-psychoactive cannabinoids in neural stem cell differentiation: relevance for Neurodegenerative diseases | Diogo Lourenço |
2023/10/16 - 2023/12/15 | Characterization of newly designed blood-brain barrier peptide shuttles | Lucija Marcelic |
2023/02/20 - 2023/06/09 | Erasmus + "Traineeship biomedical laboratory technology specialization" | Richa Guldentops |
2023/02/06 - 2023/03/17 | Visiting student - Assays to evaluate transport across the blood-brain barrier in vitro | Albert Gator |
2021/08 - 2021/09 | Visiting student - EMBO Scientific Exchange Grant (number 8731) | Antonio Zandona |
2018/09 - 2018/12 | Visiting PhD student from University Pompeu Fabra, Spain. | Maria Gallo |
2018/08 - 2018/08 | Visiting student (undergraduate) from University of Surrey, UK. | Rachel Mendes |
2016 - 2017 | Visiting PhD student from University of Brescia, Italy. | Pietro Mazzuca |
2009 - 2010 | Effect of the mycobacterium cell entry protein MCE1a on facilitating siRNA delivery into prostate cells using carbon nanotube-based vectors | Houmam Kafa |
Other jury / evaluation
Activity description | Institution / Organization | |
---|---|---|
2021/07/28 - 2021/07/28 | Provas do Curso de Doutoramento em Farmácia da Faculdade de Farmácia da Universidade de Lisboa, especialidade de Biologia Celular e Molecular, da doutoranda Joana Godinho Pereira | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Distinctions
Award
2018 | 2nd Poster prize
European Peptide Society , Ireland
|
2010 | AACR annual meeting in Washington
British Association for Cancer Research, United Kingdom
|
2009 | Nanomedicine summer school
European Science Foundation, France
|